Keyphrases
Adrenomedullin
100%
Adrenomedullin Receptor
10%
Alternatively Activated
10%
Angiogenesis
100%
Angiogenesis in Vitro
10%
Autocrine Effect
10%
B16F10
10%
Cell-conditioned Medium
10%
Clinical Significance
10%
Endothelial Cell Migration
10%
Endothelial Nitric Oxide Synthase (eNOS)
10%
Healthy Skin
10%
Human Melanoma
20%
Immunofluorescence Analysis
10%
In Vitro Growth
10%
In Vivo Model
10%
M2 Phenotype
10%
Macrophage Polarization
10%
Macrophages
10%
Melanoma
30%
Melanoma Cells
20%
Melanoma Growth
100%
Melanoma Treatment
10%
Novel Mechanism
10%
Paracrine
100%
Paracrine Effect
10%
Poor Prognosis
10%
Receptor Antagonist
10%
Signaling Pathway
10%
Tissue Microarray
10%
Tubule Formation
10%
Tumor Growth
10%
Tumor Microenvironment
10%
Tumor-associated Macrophages
100%
Medicine and Dentistry
Adrenomedullin
100%
Adrenomedullin Receptor
7%
Angiogenesis
100%
Autocrine Effect
7%
Cell Migration
7%
Clinical Significance
7%
Endothelial Cell
7%
Endothelial Nitric Oxide Synthase
7%
Immunofluorescence
7%
In Vitro
15%
Macrophage
100%
Melanoma
100%
Melanoma Cell
15%
Neoplasm
100%
Receptor
15%
Receptor Antagonist
7%
Secretion (Process)
7%
Signal Transduction
7%
Tissue Microarray
7%
Tumor Microenvironment
7%
Tumor Progression
7%
Biochemistry, Genetics and Molecular Biology
Adrenomedullin
100%
Angiogenesis
100%
Autocrine Effect
9%
Cell Migration
9%
Coculture
9%
Immunofluorescence
9%
Macrophage
18%
Nitric Oxide Synthase
9%
Receptor Antagonist
9%
Secretion (Process)
9%
Signal Transduction
9%
Tissue Microarray
9%
Tumor Progression
9%
Tumor-Associated Macrophage
100%
Immunology and Microbiology
Angiogenesis
100%
Autocrine Effect
16%
Cell Migration
16%
Coculture
16%
Immunofluorescence
16%
Immunology
16%
Macrophage
33%
Melanoma Cell
33%
Secretion (Process)
16%
Signal Transduction
16%
Tumor-Associated Macrophage
100%
Pharmacology, Toxicology and Pharmaceutical Science
Adrenomedullin
100%
Adrenomedullin Receptor
6%
Endothelial Nitric Oxide Synthase
6%
Melanoma
100%
Neoplasm
100%
Receptor
13%
Receptor Antagonist
6%
Tumor Growth
6%
Tumor Microenvironment
6%